REIDAR NORDBY

Reidar is a Mechanical Engineer graduate from Heriot-Watt University, Edinburgh. He worked in the private industry until 1988, when he was appointed CEO of the Norwegian National Lottery and stayed until the end of 2007. During this period, he was President of the World Lottery Association for six years and gained valuable experience leading an international association. He has also been Consul for Sweden in Norway for 20 years. As a myeloma patient, Reidar has been a member of the National Board of the Norwegian Blood Cancer Association since 2021. He is particularly interested in working for quicker diagnoses and strengthening government and public relations.

SOLÈNE CLAVREUL

Solène holds a PhD in Neuroscience and a Master of Biology and Physiology from Sorbonne University (Paris). She studied brain development during her PhD and then worked on brain cellular diversity as a researcher at the Helmholtz Zentrum München (Germany). Early involved in education, she has been leading holiday camps for children for many years and worked in a science museum during her studies to promote science, design exhibitions and lead workshops.

Interested in science policy and particularly in the health field, she trained herself in European policy implementation, clinical data management and industrial pharma management before joining MPE.
Solène comes from France and currently lives and works in Munich, Germany. She speaks French, English and German.

ANA VALLEJO

She holds a bachelor’s degree in journalism from the Complutense University of Madrid, a Master’s degree in Audiovisual Communication from the University Antonio de Nebrija in Madrid and a Master’s degree in Digital Communications Strategies from the Complutense University of Madrid.

Ana worked as a journalist in weekly newspapers specialising in health and consumer health monthly magazines. She has been involved in different patient advocacy groups, first as a volunteer and later on within the communications department. Since 2014, Ana has worked as a PR and press consultant in the health department of an international PR agency, developing communication strategies for prominent pharmaceutical companies.

Ana has been involved in producing two books focused on patients with cancer as a co-writer and editorial coordinator. She speaks Spanish and English.

INGRID JENISCH

She holds a degree from the advanced technical college in Ulm, Germany, and has an apprenticeship as an electrical engineering assistant.

Ingrid has broad experience in large, medium-sized and start-up companies. She worked as a referent and assistant to Executive Boards. In this role, she was responsible for the board-, management- and finance reporting and controlling. She has proficient expertise in project and programme management and implementation of administrative processes as well as in marketing and public relations.

In the health area, she worked for the Innovative Medicines Initiative (IMI) project EUPATI. The European Patients’ Academy. This is a pan-European project implemented as a public-private partnership by a collaborative multi-stakeholder consortium from the pharmaceutical industry, academia, not-for-profit, and patient organisations. As Finance and Reporting Officer, she supported the EUPATI Director in preparing reports for IMI and the international consortium members. Financial monitoring, control and analysis were part of her responsibility. Ingrid is based in Munich, Germany.